Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Shuford, Kathryn ^a   Were, Florence ^b   Awino, Norbert ^b   Samuels, Aaron ^a   Ouma, Peter ^b   Kariuki, Simon ^b   Desai, Meghna ^a   Allen, Denise Roth ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

Acceptability; Adherence; Community sensitization; Malaria elimination; Mass screen and treat; Perceptions; Qualitative methods

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; DIHYDROARTEMISININ PLUS PIPERAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ;

ADULT; ARTICLE; ATTITUDE TO ILLNESS; BLOOD SAMPLING; COMMUNITY PROGRAM; COMMUNITY SAMPLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; EXPLORATORY RESEARCH; FEAR; FEMALE; HEALTH AUXILIARY; HIV TEST; HUMAN; INTERVIEW; KENYA; MAJOR CLINICAL STUDY; MALARIA; MALE; MASS SCREENING; MEDICAL RESEARCH; PREVALENCE; PUBLIC OPINION; QUALITATIVE RESEARCH; RESEARCH SUBJECT; SOCIAL ATTITUDE; SOCIAL PARTICIPATION; SYMPTOM; YOUNG ADULT; ATTITUDE TO HEALTH; PSYCHOLOGY;

ANTIMALARIALS; ARTEMISININS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; KENYA; MALARIA; MALE; MASS SCREENING;

EID: 84957600961     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1123-y     Document Type: Article

References (31)

1. WHO. World Malaria Report 2015. Geneva: World Health Organization. 2015.
2. Snow RW, Marsh K. Malaria in Africa: Progress and prospects in the decade since the Abuja declaration. Lancet. 2010;376:137-9.
3. Silumbe K, Chiyende E, Finn TP, Desmond M, Puta C, Hamainza B, et al. A qualitative study of perceptions of a mass test and treat campaign in Southern Zambia and potential barriers to effectiveness. Malar J. 2015;14:171.
4. Okello G, Ndegwa SN, Halliday KE, Hanson K, Brooker SJ, Jones C. Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya. Malar J. 2012;11:185.
5. Atkinson JA, Bobogare A, Fitzgerald L, Boaz L, Appleyard B, Toaliu H, et al. A qualitative study on the acceptability and preference of three types of long-lasting insecticide-treated bed nets in Solomon Islands: Implications for malaria elimination. Malar J. 2009;8:119.
6. Gysels M, Pell C, Mathanga DP, Adongo P, Odhiambo F, Gosling R, et al. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J. 2009;8:191.
7. Pool R, Munguambe K, Macete E, Aide P, Juma G, Alonso P, et al. Community response to intermittent preventive treatment delivered to infants (IPTi) through the EPI system in Manhica Mozambique. Trop Med Int Health. 2006;11:1670-8.
8. Pell C, Straus L, Phuanukoonnon S, Lupiwa S, Mueller I, Senn N, et al. Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea. Malar J. 2010;9:369.
9. Pool R, Mushi A, Schellenberg J, Mrisho M, Alonso P, Montgomery C, et al. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malar J. 2008;7:213.
10. Smith LA, Jones C, Adjei RO, Antwi GD, Afrah NA, Greenwood B, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010;9:18.
11. Ansah EK, Reynolds J, Akanpigbiam S, Whitty C, Chandler C. Even if the test result is negative, they should be able to tell us what is wrong with us": A qualitative study of patient expectations of rapid diagnostic tests for malaria. Malar J. 2013;12:258.
12. Mukanga D, Tibenderana JK, Kiguli J, Pariyo GW, Waiswa P, Bajunirwe F, et al. Community acceptability of use of rapid diagnostic tests for malaria by community health workers in Uganda. Malar J. 2010;9:203.
13. Munguambe K, Pool R, Montgomery C, Bavo C, Nhacolo A, Fiosse L, et al. What drives community adherence to indoor residual spraying (IRS) against malaria in Manhicą district, rural Mozambique: A qualitative study. Malar J. 2011;10:344.
14. Tine RCK, Ndiaye P, Ndour CT, Faye B, Ndiaye JL, Sylla K, et al. Acceptability by community health workers in Senegal of combining community case management of malaria and seasonal malaria chemoprevention. Malar J. 2013;12:467.
15. Omedo MO, Matey EJ, Awiti A, Ogutu M, Alaii J, Karanja DMS, et al. Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in Western Kenya: The SCORE project. Am J Trop Med Hyg. 2012;87:1065-72.
16. Caldwell B. Mark Nichter: Global Health: Why cultural perceptions, social representations, and biopolitics matter. J Pop Research. 2009;26:203-5.
17. Geissler PW. 'Kachinja are coming!': Encounters around medical research work in a Kenyan village. Africa. 2005;75:173-202.
18. Lindblade KA, Eisele TP, Gimnig JE, Alaii JA, Odhiambo F, ter Kuile FO, et al. Sustainability of reductions in malaria transmission and infant mortality in Western Kenya with use of insecticide-treated bednets. JAMA. 2004;291:2571-80.
19. USAID. Malaria Fact Sheet-Kenya. 2013.
20. Kenya NACCo. Kenya AIDS Response Progress Report. 2014.
21. Peeters Grietens K, Ribera JM, Erhart A, Hoibak S, Ravinetto RM, Gryseels C, et al. Doctors and vampires in sub-Saharan Africa: Ethical challenges in clinical trial research. Am J Trop Med Hyg. 2014;91:213-5.
22. Geissler PW, Pool R. Editorial: Popular concerns about medical research projects in sub-Saharan Africa-a critical voice in debates about medical research ethics. Trop Med Int Health. 2006;11:975-82.
23. Brinkman I. Book review: White, L. Speaking with vampires: Rumor and history in colonial Africa. Berkeley: University of California Press, 2000. Africa Today 2001. 48:162-4.
24. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: Insights from community members on the Kenyan coast. Soc Sci Med. 2005;61:1463-73.
25. Parker M, Allen T, Hastings J. Resisting control of neglected tropical diseases: Dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. J Biosoc Sci. 2008;40:161-81.
26. Parker M, Allen T. Will mass drug administration eliminate lymphatic filariasis? Evidence from northern coastal Tanzania. J Biosoc Sci. 2013;45:517-45.
27. Dial NJ, Ceesay SJ, Gosling RD, D'Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J. 2014;13:47.
28. Marsh V, Kamuya D, Rowa Y, Gikonyo C, Molyneux S. Beginning community engagement at a busy biomedical research programme: Experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Soc Sci Med. 2008;67:721-33.
29. Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS. Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med Ethics. 2010;11:13.
30. Okello G, Jones C, Bonareri M, Ndegwa SN, Mcharo C, Kengo J, et al. Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: Experiences from Kenya. Trials. 2013;14:142.
31. Angwenyi V, Kamuya D, Mwachiro D, Kalama B, Marsh V, Njuguna P, et al. Complex realities: community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya. Trials. 2014;15:65.